Gastric-type Endocervical Adenocarcinoma: a Population-ba... | NCT06897306

Studies
Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study

NCT06897306

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Status

Completed

Last Update Posted

Mar 26, 2025Actual

Enrollment

317Actual

Phase

Not provided

Conditions

Uterine Cervical Neoplasms
Surgery
Therapy
Locally Advanced Cervical Carcinoma

Interventions

surgery

Countries

China

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Feb 2025

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Oct 1, 2024Actual

Primary Completion Date

Nov 1, 2024Actual

Completion Date

Jan 20, 2025Actual

First Submitted Date

Feb 6, 2025

First Submission Date that Met QC Criteria

Mar 20, 2025

First Posted Date

Mar 26, 2025Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Mar 20, 2025

Last Update Posted Date

Mar 26, 2025Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

This study aims to collect data of patients with Gastric-type Endocervical Adenocarcinoma from the SEER database, analyze the related prognostic factors and treatment patterns of Gastric-type Endocervical Adenocarcinoma, and explore the impact of surgical treatment on the prognosis of locally advanced Gastric-type Endocervical Adenocarcinoma.

Detailed Description

This study aims to collect data of patients with Gastric - type Endocervical Adenocarcinoma from the SEER database, analyze the related prognostic factors and treatment patterns of patients with Gastric - type Endocervical Adenocarcinoma, and explore the impact of surgical treatment on the prognosis of locally advanced Gastric - type Endocervical Adenocarcinoma.

Study subjects: Patients diagnosed with Gastric - type Endocervical Adenocarcinoma were identified using the SEER database and SEER*Stat 8.4.2 software. The search scope was the "SEER Research Plus Data, 17 Registries, Nov 2021 sub (2000 - 2019)" database, and the screening criteria included "Site and Morphology, Analytic Behavior Recode = Malignant" and "Site and Morphology, ICD - O - 3 / WHO 2008 Recode Site = Cervix". Patients with cervical Gastric - type Endocervical Adenocarcinoma were selected from the database.

Outcome measures: Overall survival (OS): The time from diagnosis to death of the patient.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

317Actual

Name	Type	Description	Arm Group Labels	Other Names
surgery	Procedure	The patient underwent surgery.

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Overall survival (OS)	The time from diagnosis to death of the patient.	The time from diagnosis to death of the patient，Assessed up to 227 months

Secondary Outcomes

Measure	Description	Time Frame
Vital status recode(study cutoff used)	Any patient that dies after the follow-up cut-off date is recoded to alive as of the cut-off date.	up to 227 months

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Patients diagnosed with Gastric - type Endocervical Adenocarcinoma were identified using the SEER database and SEER*Stat 8.4.2 software. The search scope was the "SEER Research Plus Data, 17 Registries, Nov 2021 sub (2000 - 2019)" database. The screening criteria included "Site and Morphology, Analytic Behavior Recode = Malignant" and "Site and Morphology, ICD - O - 3 / WHO 2008 Recode Site = Cervix". Patients with Gastric - type Endocervical Adenocarcinoma in the database were selected.

Exclusion Criteria:

Patients with a survival time of 0 or unknown.

Accepts Healthy Volunteers

Sex

Female

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

Not provided

Maximum Age

Not provided

Standard Ages

ChildAdultOlder Adult

Study Population

The Surveillance, Epidemiology, and End Results (SEER) database is a comprehensive source of population - based cancer incidence and survival data in the United States. The population covered by the SEER database is diverse and representative of the broader U.S. population. It includes individuals from various racial and ethnic backgrounds, age groups, and geographic regions. The data are collected from 17 population - based cancer registries, which cover approximately 28% of the U.S. population. This allows for the analysis of cancer - related outcomes and trends across different demographic and socioeconomic groups, providing valuable insights into the burden of cancer and the effectiveness of cancer - related interventions in a population - based setting.

Sampling Method

Non-Probability Sample

ID	Term
D014594	Uterine Neoplasms
D005833	Genital Neoplasms, Female
D014565	Urogenital Neoplasms
D009371	Neoplasms by Site